Global X HealthTech ETF (HEAL) Short Interest Ratio & Short Volume

Short interest is the volume of Global X HealthTech ETF shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 6,700 shares of HEAL short. 0.48% of Global X HealthTech ETF's shares are currently sold short. Learn More on Global X HealthTech ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HEAL shares currently have a short interest ratio of 1.0. Learn More on Global X HealthTech ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.48% of Global X HealthTech ETF's floating shares are currently sold short.

Global X HealthTech ETF saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 6,700 shares, a decline of 81.2% from the previous total of 35,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.48% of Global X HealthTech ETF's shares are currently sold short. Here is how the short interest of companies compare to Global X HealthTech ETF: Invesco Nasdaq Biotechnology ETF (1.71%), ProShares Ultra Nasdaq Biotechnology (1.25%), F/m Emerald Life Sciences Innovation ETF (0.10%), Horizon Kinetics Medical ETF (0.02%), First Trust Nasdaq Pharmaceuticals ETF (0.02%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (2.82%), Invesco Dorsey Wright Healthcare Momentum ETF (0.15%), VanEck Biotech ETF (0.30%), and iShares Biotechnology ETF (25.91%).

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling HEAL is an investing strategy that aims to generate trading profit from Global X HealthTech ETF as its price is falling. HEAL shares are trading down $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Global X HealthTech ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HEAL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEAL, twice per month. The most recent reporting period available is August, 31 2025.